These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9732982)

  • 1. Serum digoxin in the presence of digibind: determination of digoxin by the Abbott AxSYM and Baxter Stratus II immunoassays by direct analysis without pretreatment of serum samples.
    Ocal IT; Green TR
    Clin Chem; 1998 Sep; 44(9):1947-50. PubMed ID: 9732982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of unbound digoxin measurements by immunoassays in presence of antidote (Digibind).
    Jortani SA; Pinar A; Johnson NA; Valdes R
    Clin Chim Acta; 1999 May; 283(1-2):159-69. PubMed ID: 10404740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of digoxin immune Fab (ovine) on digoxin immunoassays.
    Rainey PM
    Am J Clin Pathol; 1989 Dec; 92(6):779-86. PubMed ID: 2686397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Indian Ayurvedic medicine Ashwagandha on measurement of serum digoxin and 11 commonly monitored drugs using immunoassays: study of protein binding and interaction with Digibind.
    Dasgupta A; Peterson A; Wells A; Actor JK
    Arch Pathol Lab Med; 2007 Aug; 131(8):1298-303. PubMed ID: 17683192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of digoxin fab antibody on the measurement of total and free digitoxin by fluorescence polarization and a new chemiluminescent immunoassay.
    Dasgupta A; Wells A; Datta P
    Ther Drug Monit; 1999 Apr; 21(2):251-5. PubMed ID: 10217348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and comparison of the TDxII, Stratus, and OPUS digoxin assays.
    Dodds HM; Norris RL; Johnson AG; Pond SM
    Ther Drug Monit; 1995 Feb; 17(1):68-74. PubMed ID: 7725380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparable effects of DIGIBIND and DigiFab in thirteen digoxin immunoassays.
    McMillin GA; Owen WE; Lambert TL; De BK; Frank EL; Bach PR; Annesley TM; Roberts WL
    Clin Chem; 2002 Sep; 48(9):1580-4. PubMed ID: 12194938
    [No Abstract]   [Full Text] [Related]  

  • 8. Problems in determining levels of free digoxin in patients treated with digoxin immune FAb.
    Honda SA; Rios CN; Murakami L; Morita T; Scottolini AG; Bhagavan NV
    J Clin Lab Anal; 1995; 9(6):407-12. PubMed ID: 8587010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digibind and free digoxin.
    Rainey P
    Clin Chem; 1999 May; 45(5):719-21. PubMed ID: 10222369
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of free serum digoxin concentrations in digoxin toxic patients after administration of digoxin fab antibodies.
    Ujhelyi MR; Green PJ; Cummings DM; Robert S; Vlasses PH; Zarowitz BJ
    Ther Drug Monit; 1992 Apr; 14(2):147-54. PubMed ID: 1585401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter study of Abbott AxSYM Digoxin II assay and comparison with 6 methods for susceptibility to digoxin-like immunoreactive factors.
    Azzazy HM; Duh SH; Maturen A; Schaller E; Shaw L; Grimaldi R; Shock G; Christenson RH
    Clin Chem; 1997 Sep; 43(9):1635-40. PubMed ID: 9299945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of digoxin Fab antibodies on five digoxin immunoassays.
    Ujhelyi MR; Cummings DM; Green P; Ellison MJ; Vlasses PH
    Ther Drug Monit; 1990 May; 12(3):288-92. PubMed ID: 2349615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Brazilian, Indian, Siberian, Asian, and North American ginseng on serum digoxin measurement by immunoassays and binding of digoxin-like immunoreactive components of ginseng with Fab fragment of antidigoxin antibody (Digibind).
    Dasgupta A; Reyes MA
    Am J Clin Pathol; 2005 Aug; 124(2):229-36. PubMed ID: 16040294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antibody specificity on results of selected digoxin immunoassays among various clinical groups.
    Datta P; Xu L; Malik S; Landicho D; Ferreri L; Halverson K; Roby PV; Zebelman AM; Kenny MA
    Clin Chem; 1996 Mar; 42(3):373-9. PubMed ID: 8598098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of digoxinlike immunoreactive substances and digoxin FAB antibodies on the new digoxin microparticle enzyme immunoassay.
    Crossey MJ; Dasgupta A
    Ther Drug Monit; 1997 Apr; 19(2):185-90. PubMed ID: 9108648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of assay methods on serum concentrations of digoxin during FAB fragment treatment.
    Banner W; Bach P; Burk B; Freestone S; Gooch WM
    J Toxicol Clin Toxicol; 1992; 30(2):259-67. PubMed ID: 1588675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of free digoxin-like immunoreactive components of oriental medicines Dan Shen and Lu-Shen-Wan by the Fab fragment of antidigoxin antibody (Digibind).
    Dasgupta A; Szelei-Stevens KA
    Am J Clin Pathol; 2004 Feb; 121(2):276-81. PubMed ID: 14983943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fab fragment of anti-digoxin antibody (digibind) binds digitoxin-like immunoreactive components of Chinese medicine Chan Su: monitoring the effect by measuring free digitoxin.
    Dasgupta A; Lopez AE; Wells A; Olsen M; Actor J
    Clin Chim Acta; 2001 Jul; 309(1):91-5. PubMed ID: 11408010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytic performance of two automated nonpretreatment digoxin immunoassays.
    De BK; Booth DD; Magee PJ; Moore ML; Preuss TM; Rose TA; Roberts WL
    Ther Drug Monit; 1999 Feb; 21(1):123-8. PubMed ID: 10051065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of severe digoxin intoxication with antidote].
    Houlberg E; Blicher TM
    Ugeskr Laeger; 2008 Oct; 170(42):3339. PubMed ID: 18940174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.